M&A Deal Summary

Grifols Acquires Kedrion - U.S. Plasma Donation Centers

On April 7, 2021, Grifols acquired leisure company Kedrion - U.S. Plasma Donation Centers from Kedrion for 55M USD

Acquisition Highlights
  • This is Grifols’ 1st transaction in the Leisure sector.
  • This is Grifols’ 3rd largest (disclosed) transaction.
  • This is Grifols’ 6th transaction in the United States.
  • This is Grifols’ 1st transaction in Delaware.

M&A Deal Summary
Date 2021-04-07
Target Kedrion - U.S. Plasma Donation Centers
Sector Leisure
Buyer(s) Grifols
Sellers(s) Kedrion
Deal Type Divestiture
Deal Value 55M USD

Target

Kedrion - U.S. Plasma Donation Centers

Wilmington, Delaware, United States
Kedrion's U.S. Plasma Donation Centers provide plasma supply through organic and inorganic growth with immediate access to approximately 1.4 million liters per year and obtain approximately 240,000 liters per year.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Grifols

Barcelona, Spain
Category Company
Founded 1909
Sector Healthcare Services
Employees23,000
Revenue 6.6B EUR (2023)
DESCRIPTION

Grifols is a global healthcare company and biopharmaceutical manufacturer. Grifols was founded in 1909 and is based in Barcelona, Spain.

DEAL STATS #
Overall 7 of 8
Sector (Leisure) 1 of 1
Type (Divestiture) 3 of 3
State (Delaware) 1 of 1
Country (United States) 6 of 6
Year (2021) 1 of 2
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-23 Bloodbuy

Dallas, Texas, United States

BloodSolutions LLC is a cloud-based marketplace that facilitates buying and selling of blood components in the U.S. BloodSolutions was founded in 2013 and is based in Dallas, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-17 Biotest

Dreieich, Germany

Biotest specializes in innovative hematology and clinical immunology solutions. The company develops, produces and markets biological medicinal products with applications in hematology, clinical immunology and intensive care. It's current portfolio includes 12 different products with a global commercial footprint in more than 90 countries. Biotest was founded in 1946 and is based in Dreieich, Germany.

Buy €1.6B

Seller(S) 1

SELLER

Kedrion

Lucca, Italy
Category Company
Founded 2001
Sector Medical Products
Employees1,000
DESCRIPTION

Kedrion is engaged in development, manufacture, and distribution of a broad range of protein products derived from human plasma. Kedrion was founded in 2001 and is based in Lucca, Italy.

DEAL STATS #
Overall 1 of 1
Sector (Leisure) 1 of 1
Type (Divestiture) 1 of 1
State (Delaware) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-15 Prometic Bioproduction

Laval, Quebec, Canada

Prometic Bioproduction has developed the first-ever FDA-approved treatment for Congenital Plasminogen Deficiency. The new drug, called Ryplazim has been approved for the treatment of all the clinical manifestations of Plasminogen Deficiency, which can lead to blindness, respiratory failure, and other severe complications.

Buy -
Mergr

Product

Company

Legal